Prostate cancer Posts on Medivizor
Navigation Menu

Prostate cancer Posts on Medivizor

Ultra-hypofractionated radiotherapy leads to similar patient-reported quality of life outcomes versus conventionally fractionated radiotherapy for prostate cancer

Ultra-hypofractionated radiotherapy leads to similar patient-reported quality of life outcomes versus conventionally fractionated radiotherapy for prostate cancer

Posted by on Feb 27, 2021 in Prostate cancer | 0 comments

In a nutshell This study compared the patient-reported quality of life outcomes between conventionally fractionated radiation treatment (CFRT) and ultra-hypofractionated radiation treatment (UHFRT) in patients with localized prostate cancer. The data showed that both radiotherapy techniques led to similar long-term outcomes. Some background Radiation...

Read More

Evaluating the long-term outcomes of regional (hockey-stick) prostate cryoablation in men with low- or intermediate-risk prostate cancer

Evaluating the long-term outcomes of regional (hockey-stick) prostate cryoablation in men with low- or intermediate-risk prostate cancer

Posted by on Feb 27, 2021 in Prostate cancer | 0 comments

In a nutshell This study reported the long-term effectiveness and quality of life outcomes after prostate cryoablation (a process that uses extreme cold to destroy prostate tumor) treatment for patients with low and intermediate-risk prostate cancer (PCa). The data showed that the treatment had good outcomes with minimal impact on urinary and sexual...

Read More

Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer

Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer

Posted by on Feb 26, 2021 in Prostate cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of stereotactic ablative radiation therapy (SABR) in the treatment of patients with oligometastatic (few metastases) cancer. The data showed that the use of SABR in these patients was associated with high overall survival and low toxicity. Some background Oligometastatic cancer (OMC)...

Read More

Evaluating long-term outcomes after high-intensity focused ultrasound for prostate cancer

Evaluating long-term outcomes after high-intensity focused ultrasound for prostate cancer

Posted by on Feb 21, 2021 in Prostate cancer | 0 comments

In a nutshell This study evaluated the long-term outcomes of patients who underwent whole-gland high-intensity focused ultrasound (HIFU) for non-metastatic prostate cancer. The data showed that HIFU has favorable outcomes in low- and intermediate-risk groups of patients. Some background HIFU is a treatment option for prostate...

Read More

Looking for participants to test an experimental Keytruda-combination study treatment for Small Cell Neuroendocrine Prostate Cancer (SCNC)

Looking for participants to test an experimental Keytruda-combination study treatment for Small Cell Neuroendocrine Prostate Cancer (SCNC)

Posted by on Feb 15, 2021 in Prostate cancer | 0 comments

In a nutshell This clinical trial is evaluating the safety and effectiveness of an experimental treatment, BXCL701, in combination with pembrolizumab (Keytruda) for people with small cell neuroendocrine prostate cancer (SCNPCa). The main outcome to be measured will be the response rate to the study treatment.   The details Prostate cancer is the...

Read More

Comparing outcomes in single-port versus multiport robotic radical prostate surgery

Comparing outcomes in single-port versus multiport robotic radical prostate surgery

Posted by on Feb 13, 2021 in Prostate cancer | 0 comments

In a nutshell This study compared the surgical outcomes of patients undergoing single-port extraperitoneal prostatectomy (SP-EPP) with conventional multiport transperitoneal robot-assisted radical prostatectomy (MP-RARP). The data showed that the SP-EPP approach was associated with a shorter length of hospital stay as well as a reduction in pain...

Read More

Evaluating the effects of radiation doses on erectile function in localized prostate cancer treated with permanent prostate brachytherapy.

Evaluating the effects of radiation doses on erectile function in localized prostate cancer treated with permanent prostate brachytherapy.

Posted by on Jan 31, 2021 in Prostate cancer | 0 comments

In a nutshell This study investigated the relationship between radiation doses in prostate brachytherapy (BT) and erectile function reduction in patients with localized prostate cancer (PCa). The data showed that sexual function decreased over time with higher doses of BT. Some background Localized prostate cancer (PCa) is a form of cancer that...

Read More

Searching for patients to trial an experimental medication for advanced solid tumors.

Searching for patients to trial an experimental medication for advanced solid tumors.

Posted by on Jan 28, 2021 in Prostate cancer | 0 comments

In a nutshell This trial is aiming to examine the safety and effectiveness of experimental treatment DF6002 alone or in combination with nivolumab (Opdivo) in the treatment of advanced solid tumors, including prostate cancer. The main outcomes to be measured are drug toxicity and the response rate of patients to the drug. This trial is being carried out...

Read More

Do statins help the treatment of patients with prostate cancer using androgen-deprivation therapy?

Do statins help the treatment of patients with prostate cancer using androgen-deprivation therapy?

Posted by on Jan 24, 2021 in Prostate cancer | 0 comments

In a nutshell This study explored the outcomes of statin (cholesterol-lowering drugs) treatment in patients with prostate cancer (PCa) undergoing androgen deprivation therapy (ADT). The authors found that the combination of statins and ADT improved the outcomes of these patients and intermittent ADT (IADT) increased the time...

Read More

Evaluating the effectiveness of enzalutamide plus androgen deprivation therapy in metastatic hormone-sensitive prostate cancer by pattern of metastatic spread

Evaluating the effectiveness of enzalutamide plus androgen deprivation therapy in metastatic hormone-sensitive prostate cancer by pattern of metastatic spread

Posted by on Jan 17, 2021 in Prostate cancer | 0 comments

In a nutshell This study examined the impact of the pattern of metastatic spread on the effectiveness of enzalutamide in combination with androgen deprivation therapy (ADT) for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC). The data showed that the combination has good outcomes in men with bone and/or lymph node...

Read More